‘3E’ project team exceed expectations!

January 29, 2018

Search for articles by category

The 3E project, funded by the Hear the World Foundation and done in partnership with the hearX Group and implementation partner – Carel du Toit Centre and Trust, aims to screen 10,000 people in underserved communities in Cape Town over a two-year period.

The project, nicknamed '3E' by the team (Ears and Eyes for Education) started with the recruitment of four screeners with no previous experience from the community. One of them was appointed project administrator. Ethical clearance was obtained from the University of Pretoria so that our team could research, document and publish the findings of the project.

2,591 consent forms were distributed at 186 Early Childhood Development Centres (EDCs). Of these, 1,960 (75,6%) were returned. 1,811 were from children eligible for screening in 2017. Another 149 children will only be old enough in 2018. Only 78 children who gave consent were not screened due to the fact that they were absent or had left the school, or their parents withdrew consent.

Hearing and vision screening commenced in September 2017 and continued to the end of November.

1,733 children aged 5 to 6 years old were tested for hearing and vision loss with hearScreen and Peek Acuity mobile applications. This far exceeded the goal, which was to reach 1,000 children by the end of December!

165 (9,5%) of these children were referred for mobile hearing screening with hearScreen, our award-winning hearing test solution on a smartphone, which, with its user-friendly design allows laypersons with minimal training to do the screening.

150 ‘first line follow-up’ hearing tests were done with our hearTest mobile application combined with otoscopy at the ECDs, which translates to a 91% first follow-up rate!

After first line follow-up, 40 children (2,3% of all the children screened or 26,7% of all first-time follow-ups) were booked for diagnostic follow-up appointments at the government hospital and 35 children were referred for ear wax removal at their local clinics.

The team has already identified 64 new ECDs where they will start screening in 2018.


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.